Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review

References

• Japan Glaucoma SocietyGuideline for Glaucoma Practice3rd edTokyoJapan Glaucoma Society20121161346 Available from: http://www.ryokunaisho.jp/guidelines/guidelines_all.pdfAccessed March 09, 2018
   Google Scholar
• LeeDAHigginbothamEJGlaucoma and its treatment: a reviewAm J Health Syst Pharm200562769169915790795
   PubMed Web of Science ®Google Scholar
• OCEBM Levels of Evidence Working GroupThe Oxford 2011 Levels of EvidenceOxfordOxford Centre for Evidence-Based Medicine2011
   Google Scholar
• DenisPLafumaAKhoshnoodBMimaudVBerdeauxGA meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapyCurr Med Res Opin200723360160817355741
   PubMed Web of Science ®Google Scholar
• AptelFCucheratMDenisPEfficacy and tolerability of prostaglandin-timolol fixed combinations: a meta-analysis of randomized clinical trialsEur J Ophthalmol201222151822167538
   PubMed Web of Science ®Google Scholar
• ChengJWChengSWGaoLDLuGCWeiRLIntraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysisPLoS One201279e4507923028770
   PubMed Web of Science ®Google Scholar
• QuarantaLBiagioliERivaIProstaglandin analogs and timolol-fixed versus unfixed combinations or monotherapy for open-angle glaucoma: a systematic review and meta-analysisJ Ocul Pharmacol Ther201329438238923231442
   PubMed Web of Science ®Google Scholar
• WangYQWangXLiuPMeta analysis about the efficacy and safety of anti-ocular hypertension eye drops without benzalkonium chlorideAsian Pac J Trop Med20136121004100824144037
   PubMed Web of Science ®Google Scholar
• LouHWangHZongYChengJWWeiRLEfficacy and tolerability of prostaglandin-timolol fixed combinations: an updated systematic review and meta-analysisCurr Med Res Opin20153161139114725867658
   PubMed Web of Science ®Google Scholar
• LiTLindsleyKRouseBComparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysisOphthalmology2016123112914026526633
   PubMed Web of Science ®Google Scholar
• LiJLinXYuMMeta-analysis of randomized controlled trials comparing latanoprost with other glaucoma medications in chronic angle-closure glaucomaEur J Ophthalmol2015251182625044139
   PubMed Web of Science ®Google Scholar
• StewartWCKonstasAGNelsonLAKruftBMeta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicinesOphthalmology200811571117112218082886
   PubMed Web of Science ®Google Scholar
• IwaseASuzukiYAraieMTajimi Study Group, Japan Glaucoma SocietyThe prevalence of primary open-angle glaucoma in Japanese: the Tajimi StudyOphthalmology200411191641164815350316
   PubMed Web of Science ®Google Scholar
• YamamotoSSawaguchiSIwaseAPrimary open-angle glaucoma in a population associated with high prevalence of primary angle-closure glaucoma: the Kumejima StudyOphthalmology201412181558156524746386
   PubMed Web of Science ®Google Scholar
• InoueKMasumotoMWakakuraMTomitaGOcular hypotensive effects and safety of latanoprost without benzalkonium hydrochloride (article in Japanese)Atarashii Ganka2011281116351639
   Google Scholar
• KimuraHNozakiMOguraYKimuraAArimuraKTaniharaHOcular hypotensive effect of latanoprost monotherapy for untreated glaucomas (article in Japanese)Rinsho Ganka2003575700704
   Google Scholar
• IwataSEndouYSaitouHEfficacy of latanoprost 0.005% once daily in normal-tension glaucoma (article in Japanese)Atarashii Ganka2003205709711
   Google Scholar
• NaitoTOkumaSNagayamaMSustainability of intraocular pressure reduction of travoprost ophthalmic solution in subjects with normal tension glaucomaAdv Ther201633343544626861847
   PubMed Web of Science ®Google Scholar
• NagashimaSInoueKShiokawaMHypotensive effect of travoprost ophthalmic solution for normal-tension glaucoma (article in Japanese)Rinsho Ganka2010646911914
   Google Scholar
• AraiKInoueKShiokawaMMasumotoMWakakuraMTomitaGShort-term effect of bimatoprost ophtalmic solution for normal-tension glaucoma (article in Japanese)Rinsho Ganka201165710831087
   Google Scholar
• OkadaFInoueKWakakuraMTomitaGOcular hypotensive effects and safety of tafluprost in normal-tension glaucoma (article in Japanese)Atarashii Ganka201128710431046
   Google Scholar
• SoneAKatsushimaHFunahashiKNishinoKTakedaAEfficacy and safety of 0.0015% tafluprost ophthalmic solution in normal-tension glaucoma (article in Japanese)Atarashii Ganka2011284568570
   Google Scholar
• NakanoTYoshikawaKKimuraTSuzumuraHNannoMNoroTEfficacy and safety of tafluprost in normal-tension glaucoma with intraocular pressure of 16 mmHg or lessJpn J Ophthalmol201155660561321874307
   PubMed Web of Science ®Google Scholar
• MiyagawaYYamazakiHNakazawaMShort-term efficacy of tafluprost monotherapy for untreated glaucoma (article in Japanese)Atarashii Ganka2010277967969
   Google Scholar
• KuwayamaYKomemushiSTafluprost Multi-center Study GroupIntraocular pressure lowering effect of 0.0015% tafluprost as compared to placebo in patients with normal tension glaucoma: randomized, double-blind, multicenter, phase III studyNippon Ganka Gakkai Zasshi2010114543644320545217
   PubMedGoogle Scholar
• InoueKSetogawaATomitaGNonresponders to prostaglandin analogs among normal-tension glaucoma patientsJ Ocul Pharmacol Ther2016322909626624245
   PubMed Web of Science ®Google Scholar
• NakamotoKYasudaNEffect of concomitant use of latanoprost and brinzolamide on 24-hour variation of IOP in normal-tension glaucomaJ Glaucoma200716435235717570997
   PubMed Web of Science ®Google Scholar
• NakamotoKNannoMKinohiraYMuraiKYasudaNIntraocular pressure reduction and optic disc changes with latanoprost treatment in normal-tension glaucoma (article in Japanese)Atarashii Ganka2001181114171419
   Google Scholar
• NakamotoKYasudaNNannoMKinohiraYMuraiKFukudaTEffect of latanoprost on diurnal variations of intraocular pressure in normal-tension glaucomaNippon Ganka Gakkai Zasshi2003107953053414531313
   PubMedGoogle Scholar
• NakamotoKYasudaNNannoMFukudaTComparison of the effects of latanoprost and timolol gel-forming solution on diurnal variation of intraocular pressure in normal-tension glaucomaNippon Ganka Gakkai Zasshi2004108740140715359902
   PubMedGoogle Scholar
• IshibashiSHiroseNTawaraAEffect of latanoprost on diurnal variations in intraocular and ocular perfusion pressure in normal-tension glaucoma (article in Japanese)Atarashii Ganka2004211216931696
   Google Scholar
• IshibashiSHiroseNTawaraAKubotaTEffect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucomaJ Glaucoma200615535435716988595
   PubMed Web of Science ®Google Scholar
• HashimotoNHaraTTsuruTSelection of therapeutic modality by four-week latanoprost followed by additional timolol-gel ophthalmic solution (article in Japanese)Rinsho Ganka2006605757759
   Google Scholar
• HashimotoTHaraTTakahashiYKubotaSKubotaMTsuruTShort and long-term hypotensive effect of timolol-gel and latanoprost instillation in normal-tension glaucomaNippon Ganka Gakkai Zasshi2004108847748115457989
   PubMedGoogle Scholar
• KoEOkamotoYInoueTTaniharaHEfficacy of latanoprost as first-line drug and comparison of timolol and dorzolamide in the additive effect for normal tension glaucoma (article in Japanese)Ganka Rinsho Kiyou201367533537
   Google Scholar
• SunanagaTKawanoSEffect of topical latanoprost as the initial treatment for glaucoma (article in Japanese)Rinsho Ganka2010642207211
   Google Scholar
• SugiyamaTKojimaSIshidaOIkedaTChanges in optic nerve head blood flow induced by the combined therapy of latanoprost and beta blockersActa Ophthalmol200987779780019053956
   PubMed Web of Science ®Google Scholar
• MizoueSNakanoTFuseNIwaseAMatsumotoSYoshikawaKTravoprost with sofZia® preservative system lowered intraocular pressure of Japanese normal tension glaucoma with minimal side effectsClin Ophthalmol2014834735424520191
   PubMedGoogle Scholar
• MizoguchiTOzakiMUnokiKDakeYEtoTAraiMA randomized crossover study comparing tafluprost 0.0015% with travoprost 0.004% in patients with normal-tension glaucomaClin Ophthalmol201261579158423055682
   PubMedGoogle Scholar
• TanabeYKannoMYamashitaHIntraocular pressure-lowering effect of travoprost, tafluprost and bimatoprost in normal tension glaucoma (article in Japanese)Atarashii Ganka201229811311135
   Google Scholar
• NomuraYNakakuraSMoriwakiMTakahashiYShirakiKEffect of travoprost on 24-hour intraocular pressure in normal tension glaucomaClin Ophthalmol2010464364720689776
   PubMedGoogle Scholar
• AiharaMProstaglandin analogues (article in Japanese)Atarashii Ganka2010271013471356
   Google Scholar
• LiangYWoodwardDFGuzmanVMIdentification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexesBr J Pharmacol200815451079109318587449
   PubMed Web of Science ®Google Scholar
• BeanGWCamrasCBCommercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differencesSurv Ophthalmol200853Suppl 1S69S8419038626
   PubMed Web of Science ®Google Scholar
• SakuraiMHigashideTTakahashiMSugiyamaKAssociation between genetic polymorphisms of the prostaglandin F2alpha receptor gene and response to latanoprostOphthalmology200711461039104517467803
   PubMed Web of Science ®Google Scholar
• SakuraiMHigashideTOhkuboSTakedaHSugiyamaKAssociation between genetic polymorphisms of the prostaglandin F2α receptor gene, and response to latanoprost in patients with glaucoma and ocular hypertensionBr J Ophthalmol201498446947324457363
   PubMed Web of Science ®Google Scholar
• GaoLCWangDLiuFQInfluence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patientsEur J Clin Pharmacol2015711435025339146
   PubMed Web of Science ®Google Scholar
• UssaFFernandezIBrionMAssociation between SNPs of metalloproteinases and prostaglandin F2α receptor genes and latanoprost response in open-angle glaucomaOphthalmology201512251040104825704319
   PubMed Web of Science ®Google Scholar
• LiuHYangZKLiYZhangWJWangYTDuanXCABCB1 variants confer susceptibility to primary open-angle glaucoma and predict individual differences to latanoprost treatmentBiomed Pharmacother20168011512027133047
   PubMed Web of Science ®Google Scholar